MENU
+Compare
BAK
Stock ticker: NYSE
AS OF
Jan 14 closing price
Price
$3.25
Change
+$0.09 (+2.85%)
Capitalization
1.23B

BAK Braskem SA Forecast, Technical & Fundamental Analysis

Braskem SA manufactures and sells chemicals, petrochemicals, fuels, and utilities... Show more

BAK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for BAK with price predictions
Jan 14, 2026

BAK in +4.17% Uptrend, advancing for three consecutive days on January 14, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BAK advanced for three days, in of 265 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on January 08, 2026. You may want to consider a long position or call options on BAK as a result. In of 77 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BAK just turned positive on January 09, 2026. Looking at past instances where BAK's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

BAK moved above its 50-day moving average on December 19, 2025 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BAK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

BAK broke above its upper Bollinger Band on January 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BAK entered a downward trend on December 26, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: BAK's P/B Ratio (142.857) is very high in comparison to the industry average of (5.017). P/E Ratio (0.000) is within average values for comparable stocks, (43.223). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.897). BAK has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.036). P/S Ratio (0.094) is also within normal values, averaging (19.281).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BAK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BAK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.

View a ticker or compare two or three
BAK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BAK is expected to report earnings to fall 277.41% to -99 cents per share on March 11

Braskem SA BAK Stock Earnings Reports
Q4'25
Est.
$-1.00
Q3'25
Beat
by $0.98
Q2'25
Beat
by $0.37
Q1'25
Beat
by $0.24
Q4'24
Missed
by $0.72
The last earnings report on November 10 showed earnings per share of 56 cents, beating the estimate of -41 cents. With 1.47M shares outstanding, the current market capitalization sits at 1.23B.
A.I.Advisor
published Dividends

BAK paid dividends on May 12, 2022

Braskem SA BAK Stock Dividends
А quarterly dividend of $0.67 per share was paid with a record date of May 12, 2022, and an ex-dividend date of April 20, 2022. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of petrochemicals and other related products

Industry ChemicalsMajorDiversified

Profile
Fundamentals
Details
Industry
Chemicals Specialty
Address
Rua Lemos Monteiro
Phone
+55 1135769000
Employees
8668
Web
https://www.braskem.com.br
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GQHPX13.340.20
+1.52%
GQG Partners US Quality Value Fund Inv
NPNRX53.630.49
+0.92%
Neuberger Large Cap Value R3
QICLX17.570.11
+0.63%
AQR International Multi-Style I
LADCX12.20N/A
N/A
Lord Abbett Developing Growth C
LZSCX12.41-0.01
-0.08%
Lazard US Small Cap Equity Select Instl

BAK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BAK has been loosely correlated with AVNT. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BAK jumps, then AVNT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAK
1D Price
Change %
BAK100%
+2.85%
AVNT - BAK
45%
Loosely correlated
+0.87%
DOW - BAK
43%
Loosely correlated
+6.44%
SCL - BAK
42%
Loosely correlated
+0.08%
DD - BAK
42%
Loosely correlated
-2.06%
LYB - BAK
42%
Loosely correlated
+6.84%
More

Groups containing BAK

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BAK
1D Price
Change %
BAK100%
+2.85%
Chemicals: Major Diversified
industry (61 stocks)
9%
Poorly correlated
+0.86%